We are live on ! Find out more
MAP

Moody Aldrich Partners Portfolio holdings

AUM $557M
1-Year Est. Return 122.79%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+122.79%
3 Year Est. Return
+335.86%
5 Year Est. Return
+437.05%
10 Year Est. Return
+2,951.39%
AUM
$528M
AUM Growth
+$13M
Cap. Flow
+$23.8M
Cap. Flow %
4.5%
Top 10 Hldgs %
19.23%
Holding
222
New
70
Increased
61
Reduced
51
Closed
30

Sector Composition

Rank Sector Weight
1 Healthcare 16.44%
2 Industrials 14.99%
3 Financials 14.57%
4 Technology 13.45%
5 Energy 10.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
META icon
101
Meta Platforms (Facebook)
META
$1.51T
$1.44M 0.27%
4,785
-1,961
-29% -$591K
BBY icon
102
Best Buy
BBY
$17.3B
$1.44M 0.27%
20,661
WFG icon
103
West Fraser Timber
WFG
$5.65B
$1.36M 0.26%
+18,600
New +$1.46M
LNTH icon
104
Lantheus
LNTH
$6.59B
$1.34M 0.25%
19,333
-22,530
-54% -$1.65M
VTYX
105
DELISTED
Ventyx Biosciences
VTYX
$1.32M 0.25%
37,988
+1,491
+4% +$51.5K
OC icon
106
Owens Corning
OC
$12.4B
$1.25M 0.24%
9,192
-3,530
-28% -$485K
TROW icon
107
T. Rowe Price
TROW
$24.3B
$1.25M 0.24%
11,901
DFS
108
DELISTED
Discover Financial Services
DFS
$1.21M 0.23%
13,923
TMDX icon
109
Transmedics
TMDX
$2.91B
$1.21M 0.23%
22,022
-5,839
-21% -$420K
RCKT icon
110
Rocket Pharmaceuticals
RCKT
$394M
$1.19M 0.23%
+58,027
New +$1.05M
AB icon
111
AllianceBernstein
AB
$3.47B
$1.17M 0.22%
38,559
-17,559
-31% -$558K
PRTA icon
112
Prothena Corp
PRTA
$450M
$1.15M 0.22%
23,904
-13,695
-36% -$814K
PTGX icon
113
Protagonist Therapeutics
PTGX
$9.44B
$1.15M 0.22%
68,968
+27,108
+65% +$526K
LEN icon
114
Lennar Class A
LEN
$21.2B
$1.12M 0.21%
10,342
-10,587
-51% -$1.24M
ALKS icon
115
Alkermes
ALKS
$8.25B
$1.12M 0.21%
+40,074
New +$1.17M
LLY icon
116
Eli Lilly
LLY
$1.06T
$1.03M 0.2%
+1,885
New +$971K
MSFT icon
117
Microsoft
MSFT
$3.71T
$1.01M 0.19%
+3,149
New +$1.04M
SRPT icon
118
Sarepta Therapeutics
SRPT
$1.77B
$876K 0.17%
+7,227
New +$817K
AMGN icon
119
Amgen
AMGN
$222B
$860K 0.16%
+3,199
New +$798K
MRK icon
120
Merck
MRK
$318B
$846K 0.16%
+8,184
New +$882K
VRTX icon
121
Vertex Pharmaceuticals
VRTX
$126B
$833K 0.16%
+2,393
New +$837K
NVDA icon
122
NVIDIA
NVDA
$5.42T
$689K 0.13%
+15,570
New +$698K
BIIB icon
123
Biogen
BIIB
$30.7B
$650K 0.12%
+2,530
New +$677K
MRNA icon
124
Moderna
MRNA
$23.6B
$646K 0.12%
+6,258
New +$698K
DECK icon
125
Deckers Outdoor
DECK
$13.3B
$613K 0.12%
7,152
-156
-2% -$14K

Similar funds

Moody Aldrich Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Moody Aldrich Partners held 222 positions worth $528M, up 2.5% from $515M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Moody Aldrich Partners deployed $23.8M of net new capital in Q3 2023, opening 70 new positions and adding to 61 existing holdings. Its largest new stake was Permian Resources: 678,511 shares worth $9.47M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was BWX Technologies, an estimated $4.86M trimmed.

  • Moody Aldrich Partners's largest Q3 2023 buy was Permian Resources: 678,511 shares worth $9.47M.
  • Moody Aldrich Partners added most to Vaxcyte in Q3 2023, an estimated $5.7M increase.
  • Moody Aldrich Partners's biggest Q3 2023 reduction was BWX Technologies, cutting an estimated $4.86M.
  • Moody Aldrich Partners fully exited Green Plains in Q3 2023, selling an estimated $6.34M.
  • Moody Aldrich Partners's ten largest holdings make up 19% of its $528M portfolio in Q3 2023.
  • Moody Aldrich Partners opened 70 new positions and closed 30 in Q3 2023.
  • Moody Aldrich Partners's portfolio value rose 2.5% quarter-over-quarter to $528M.

Based on Moody Aldrich Partners's 13F filing for Q3 2023, filed 8 Nov 2023.